FDA Puts Strict Limits on Oral Ketoconazole Use

			July 26, 2013
				SILVER SPRING, Md. -- Oral ketoconazole (Nizoral) should never be used as first-line therapy for any fungal infection because of the risk of liver toxicity and interactions with other drugs, the FDA said Friday Fuente:  http://www.medpagetoday.com/InfectiousDisease/GeneralInfectiousDisease/40710?isalert=1&uun=g419731d167R5519153u&utm_source=breaking-news&utm_medium=email&utm_campaign=breaking-news&xid=NL_breakingnews_2013-07-26